Abstract
Transcranial magnetic stimulation (TMS) is a method of using high-strength pulsed magnetic fields to induce a depolarizing electric current in a localized area of the cerebral cortex. A large, replicated body of multisite, randomized sham-controlled studies has established the safety and effectiveness of a specific TMS device for the treatment of patients with pharmacoresistant major depressive disorder. This chapter reviews the current understanding of the physiologic effects and presumed mechanism of effect of TMS as an antidepressant. In addition, the scientific evidence base for its safety and efficacy are reviewed, along with a summary of its current acceptance by professional societies. The introduction of TMS as an office-based treatment in clinical psychiatry has introduced the need to understand the basic elements of organization and implementation of a TMS treatment option within a psychiatric clinical practice setting. This chapter provides a broad overview and specific recommendations for the organization of a TMS treatment team, and presents a basic framework and clinical approach to the implementation of TMS as a therapeutic technique. Aspects of patient diagnostic assessment, treatment planning, treatment team roles and responsibilities, and patient safety are reviewed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Speer AM, Kimbrell TA, Wassermann EM et al (2000) Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry 48: 1133–1141
Huang Y-Z, Rothwell JC, Chen R-S, Lu C-S, Chuang W-L (2011) The theoretical model of theta burst form of repetitive transcranial magnetic stimulation. Clin Neurophysiol 122: 1011–1018
Drevets WC (1998) Functional neuroimaging studies of depression: the anatomy of melancholia. Annu Rev Med 49:341–361
Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, Silva JA, Tekell JL, Martin CC, Lancaster JL, Fox PT (1999) Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 156: 675–682
Pizzagalli DA (2011) Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 36: 183–206
Kito S, Fujita K, Koga Y (2008) Changes in regional cerebral blood flow after repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in treatment resistant depression. J Neuropsychiatry Clin Neurosci 20:74–80
Cohrs S, Tergau F, Riech S, Kastner S, Paulus W, Ziemann U, Ruther E, Hajak G (1998) High-frequency repetitive transcranial magnetic stimulation delays rapid eye movement sleep. Neuroreport 9:3439–3443
Pridmore S (1999) Rapid transcranial magnetic stimulation and normalization of the dexamethasone suppression test. Psychiatry Clin Neurosci 53:33–37
Sachdev PS, McBride R, Loo C, Mitchell PM, Malhi GS, Croker V (2002) Effects of different frequencies of transcranial magnetic stimulation (TMS) on the forced swim test model of depression in rats. Biol Psychiatry 51: 474–479
Post A, Keck ME (2001) Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms? J Psychiatr Res 35: 193–215
Holtzheimer PE et al (2001) A meta-analysis of repetitive transcranial magnetic stimulation in the treatment of depression. Psychopharmacol Bull 35:149–169
Kozel FA, George MS (2002) Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation to treat depression. J Psychiatr Pract 8:270–275
Martin JLR, Barbanoj MJ, Schlaepfer TE, Clos S, Perez V, Kulisevsky J, Gironelli A (2002) Transcranial magnetic stimulation for treating depression. Cochrane Database Syst Rev (2):CD003493
Burt T et al (2002) Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol 5:73–103
Aarre TF, Johansen JB et al (2003) Efficacy of repetitive transcranial magnetic stimulation in depression: a review of the evidence. Nord J Psychiatry 57:227–232
Couturier J (2005) Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. J Psychiatry Neurosci 30(2): 83–90
Loo C, Mitchell P (2005) A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy. J Affect Disord 88:255–267
Herrmann L, Ebmeier K (2006) Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review. J Clin Psychiatry 67:1870–1876
Gross M, Nakamura L et al (2007) Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatr Scand 116:165–173
Lam RW et al (2008) Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. Can J Psychiatry 53(9):621–631
Schutter DJLG (2009) Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med 39:65–75
Slotema CW, Blom JD, Hoek HW, Sommer IEC (2010) Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry 71(7):873–884
Allan C (2011) Transcranial magnetic stimulation in the management of mood disorders. Neuropsychobiology 64:163–169
Agency for Healthcare Research and Quality, Effective Health Care Program, Comparative Effectiveness Review Number 33. Nonpharmacologic interventions for treatment-resistant depression in adults. http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides- reviews-and-reports/?pageaction=displayproduct&productid=787
Demitrack MA, Thase ME (2009) Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data. Psychopharmacol Bull 42(2):5–38
Janicak PG, O’Reardon JP, Sampson SM, Husain MM, Lisanby SH, Rado JT, Demitrack MA (2008) Transcranial magnetic stimulation (TMS) in the treatment of major depression: a comprehensive summary of safety experience from acute and extended exposure and during reintroduction treatment. J Clin Psychiatry 69(2):222–232
O’Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, McDonald WM, Avery D, Fitzgerald PB, Loo C, Demitrack MA, George MS, Sackeim HA (2007) Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multi-site randomized controlled trial. Biol Psychiatry 62:1208–1216
George MS et al (2010) Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder a sham-controlled randomized trial. Arch Gen Psychiatry 67(5): 507–516
Avery DH, Isenberg KE, Sampson SM, Janicak PG, Lisanby SH, Maixner MD, Loo C (2008) TMS in the acute treatment of major depression: clinical response in an open-label extension trial. J Clin Psychiatry 69(3):441–451
McDonald WM, Durkalski V, Ball ER, Holtzheimer PE, Pavlicova M, Lisanby SH, Avery D, Anderson BS, Nahas Z, Zarkowski P, Sackeim HA, George MS (2011) Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depress Anxiety 28(11):973–980
Carpenter LL, Janicak PG, Aaronson ST, Boyadjis T, Brock DG, Cook IA, Dunner DL, Lanocha K, Solvason HB, Demitrack MA (2012) Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety 29(7):587–596
Rossi S, Hallett M, Rossini PM, Pascual-Leone A (2009) Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 120:2008–2039
Chen R, Gerloff C, Classen J, Wassermann EM, Hallett M, Cohen LG (1997) Safety of different inter-train intervals for repetitive transcranial magnetic stimulation and recommendations for safe ranges of stimulation parameters. Electroencephalogr Clin Neurophysiol 105: 415–421
Rush AJ et al (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163:1905–1917
Kennedy SH, Milev R, Giacobbe P, Ramasubbu R, Lam RW, Parikh SV, Patten SB, Ravindran AV (2009) Canadian network for mood and anxiety treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. J Affect Disord 117:S44–S53
Schlaepfer TE, George MS et al (2009) WFSBP guidelines on brain stimulation treatments in psychiatry. World J Biol Psychiatry 1:1–17
Sackeim HA (2001) The definition and meaning of treatment-resistant depression. J Clin Psychiatry 16:10–17
Hadley D, Anderson BS, Borckardt JJ, Arana A, Li X, Nahas Z, George MS (2011) Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. J ECT 27(1):18–25
Fitzgerald P, Benitez J, de Castella A, Daskalakis ZJ, Brown TL, Kulkarni J (2006) A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry 163:88–94
Fitzgerald PB, Hoy K, Gunewardene R, Slack C, Ibrahim S, Bailey M, Daskalakis ZJ (2011) A randomized trial of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in treatment-resistant major depression. Psychol Med 41(6):1187–1196
Fitzgerald PB, Hoy KE, Herring SE, McQueen S, Peachey AV, Segrave RA, Maller J, Hall P, Daskalakis ZJ (2012) A double blind randomized trial of unilateral left and bilateral prefrontal cortex transcranial magnetic stimulation in treatment resistant major depression. J Affect Disord 139:193–198
Herwig U, Padberg F, Unger J, Spitzer M, Schoenfeldt-Leucona C (2001) Transcranial magnetic stimulation in therapy studies: examination of the reliability of “standard” coil placement positioning by neuronavigation. Biol Psychiatry 50:58–61
Fitzgerald PB, Hoy K, McQueen S, Maller JJ, Herring S, Segrave R, Bailey M, Been G, Kulkarni J, Daskalakis ZJ (2009) A randomized trial of rTMS targeted with MRI based neuronavigation in treatment resistant depression. Neuropsychopharmacology 34(5):1255–1262
Herbsman T, Avery D, Ramsey D, Holtzheimer P, Wadjik C, Hardaway F, Haynor D, George MS, Nahas Z (2009) More lateral and anterior prefrontal coil location is associated with better repetitive transcranial magnetic stimulation antidepression response. Biol Psychiatry 66(5): 509–515
Pridmore S, Filho JAF, Nahas Z, Liberatos C, George MS (1998) Motor threshold in transcranial magnetic stimulation: a comparison of a neurophysiological method and a visualization of movement method. J ECT 14(1): 25–27
Janicak PG et al (2010) Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a six-month, multisite, open-label study. Brain Stimul 3:187–199
Pascual-Leone A, Houser CM et al (1993) Safety of rapid-rate transcranial magnetic stimulation in normal volunteers. Electroencephalogr Clin Neurophysiol 89(2):120–130
Loo C, Sachdev P et al (2001) Effects of a 2 to 4-week course of repetitive transcranial magnetic stimulation (rTMS) on neuropsychologic functioning, eletroencephalogram, and auditory threshold in depressed patients. Biol Psychiatry 49:615–623
Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9): 606–613
Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB (2003) The 16-item quick inventory of depressive symptomatology (QIDS) clinician rating (QIDS-C) and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 54:573–583
Gelenberg AJ, Freeman MP, Markowitz JC, Rosenbaum JF, Thase ME, Trivedi MH, Van Rhoads RS (eds) (2010) Practice guidelines for the treatment of patients with major depressive disorder, 3rd edn. American Psychiatric Association, Arlington, VA
Horvath JC, Mathews J, Demitrack MA, Pascual-Leone A (2010) The NeuroStar TMS device: conducting the FDA approved protocol for treatment of depression. J Vis Exp 45:2345
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Demitrack, M.A., Brock, D.G. (2014). A Review of Current Clinical Practice in the Treatment of Major Depression. In: Rotenberg, A., Horvath, J., Pascual-Leone, A. (eds) Transcranial Magnetic Stimulation. Neuromethods, vol 89. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0879-0_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0879-0_14
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0878-3
Online ISBN: 978-1-4939-0879-0
eBook Packages: Springer Protocols